Compare IDEXX Laboratories, Inc. (IDXX) vs PPG Industries, Inc. (PPG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
IDEXX Laboratories, Inc. vs PPG Industries, Inc. — how do they compare? IDEXX Laboratories, Inc. trades at $573.33 (market cap $46.22B), while PPG Industries, Inc. trades at $114.96 (market cap $25.82B). The key difference: IDEXX Laboratories, Inc. is the larger of the two by market cap, and PPG Industries, Inc. pays a 2.55% dividend while IDEXX Laboratories, Inc. pays none. Which is the better fit depends on your goals.
| IDXX | PPG | |
|---|---|---|
Market Cap | $46.22B | $25.82B |
Sector | Health | Basic Materials |
52-Week High | $766.68 | $131.56 |
52-Week Low | $526.44 | $94.34 |
Enterprise Value | $47.12B | $31.69B |
Dividend Yield | — | 2.55% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IDEXX Laboratories (IDXX) trades at $571.44, down 4.08% over the past day, amid a mixed technical and strong fundamental backdrop. The stock shows a bullish trend in moving averages but overbought RSI readings near 73. Recent Q2 2026 earnings beat expectations with 9% organic revenue growth, and the company raised full-year EPS guidance. Profitability remains robust with a 25.03% net income margin and 74.21% ROE.
The outlook is positive given strong earnings momentum, high analyst buy ratings, and a consensus price target of $683.33 implying ~20% upside. Risks include premium valuation multiples and potential market volatility. The stock presents a growth opportunity supported by durable competitive advantages in veterinary diagnostics.
PPG Industries trades at $114.90, down 0.49% on the day, with mixed technical signals showing neutral momentum. The company maintains solid fundamentals with $15.88B in 2025 revenue, 9.57% net margin, and strong cash flow generation. Recent Q2 2026 earnings of $2.23 per share slightly missed expectations despite 7% sales growth. Analyst sentiment remains positive with 55% buy ratings and a $129.17 consensus price target representing 12% upside potential.
PPG offers attractive valuation with 16.67 P/E and dividend growth potential, but faces margin pressure from raw material costs. The stock presents a balanced opportunity for income and value investors, though macroeconomic headwinds and competitive pressures require monitoring. The recent dividend increase to $0.74 per share reinforces management's confidence in long-term cash flow stability.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About IDEXX Laboratories, Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →About PPG Industries, Inc.
PPG is a global producer of coatings. The company is the world's largest producer of coatings after the purchase of selected Akzo Nobel assets. PPG's products are sold to a wide variety of end users, including the automotive, aerospace, construction, and industrial markets. The company has a footprint in many regions around the globe, with less than half of sales coming from North America in recent years. PPG is focused on its coatings and specialty products and expansion into emerging regions, as exemplified by the Comex acquisition.
Read more on PPG →
